Tilray Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The company offers cannabis-lifestyle and consumer packaged goods, offers medical cannabis in extracts and dried flower forms; and cannabis extracts, including purified oil drops and capsules.
Revenue TTM 480M
EBITDA TTM 36M
Gross Margin 35%
EBITDA margin 9.2%
RSI Oversold
Revenue TTM 480M
EBITDA TTM 36M
Gross Margin 35%
EBITDA margin 9.2%
RSI Oversold
Trade closed manually
$15.70 July 28
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.